PAM
JSPRW icon

Panagora Asset Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Panagora Asset Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,729
Closed -$3K – 2865
2021
Q1 		$3K Hold
3,729
– – ﹤0.01% 2663
2020
Q4 		$5K Sell
3,729
-144
-4% -$181 ﹤0.01% 2462
2020
Q3 		$5K Buy
+3,873
New +$3.92K ﹤0.01% 2450

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return

Panagora Asset Management's JSPRW Position: Q2 2021 in Review

Panagora Asset Management sold out of Japer Therapeutics Warrants (JSPRW) in Q2 2021, closing a stake of 3,729 shares — an estimated $3K sold.

Panagora Asset Management first reported a position in JSPRW in Q3 2020 and held it in 3 quarters. The position peaked at $5K in Q4 2020. 20 funds tracked by Wall St. Rank hold JSPRW as of Q2 2021.

  • Panagora Asset Management reported no remaining Japer Therapeutics Warrants position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 3,729 Japer Therapeutics Warrants shares in Q2 2021, an estimated $3K.
  • Panagora Asset Management first reported a position in Japer Therapeutics Warrants in Q3 2020 and held it in 3 quarters.
  • Panagora Asset Management's Japer Therapeutics Warrants position peaked at $5K in Q4 2020.
  • 20 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.